Bullish
MAIA Biotechnology has received FDA clearance for an amended Investigational New Drug (IND) application, allowing U.S. enrollment in the expanded Phas...
Bullish
MAIA Biotechnology's CEO, Vlad Vitoc, M.D., and Director, Stan V. Smith, Ph.D., significantly increased their ownership stakes through open market pur...
Bullish
MAIA Biotechnology's founder and CEO, Vlad Vitoc, and Director Stan V. Smith, have made open market purchases of MAIA common stock, acquiring approxim...